U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9711197111A Pharmacodynamics, Pharmacokinetics, and Safety Study of Hydrochlorothiazide and Canagliflozin in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Canagliflozin 300 mg once daily and HCTZ 25 mg once dailyhttps://ClinicalTrials.gov/show/NCT01294631
9711297112Nilotinib + Pegylated Interferon Alpha 2a for Untreated Chronic Phase Chronic Myelogenous LeukemiaCompletedNo Results AvailableChronic Myelogenous LeukemiaDrug: Nilotinib,Novartis,300 mg twice a day +Pegylated interferon 2a,Roche, 45 microg weekly starting Month 2-Month 12 or beyond according to investigator choice.https://ClinicalTrials.gov/show/NCT01294618
9711397113Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)CompletedNo Results AvailableDiphtheria|Tetanus and PertussisBiological: Boostrixâ„¢ (dTpa)|Biological: GSK Biologicals' reduced-antigen-content combined diphtheria, tetanus, acellular pertussis and inactivated polio vaccine (dTpa-IPV; BoostrixTM)|Biological: Ditanrixâ„¢ Adult, TedivaxTM (Td)|Biological: Ditanrixâ„¢ Adult, TedivaxTM (Td)https://ClinicalTrials.gov/show/NCT01294605
9711497114Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate EnlargementCompletedHas ResultsProstatic HyperplasiaDrug: Dutasteride plus tamsulosin|Drug: tamsulosinhttps://ClinicalTrials.gov/show/NCT01294592
9711597115Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL)RecruitingNo Results AvailableLymphoma, Non-HodgkinBiological: Ofatumumab|Drug: Bendamustinehttps://ClinicalTrials.gov/show/NCT01294579
9711697116FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese VolunteersCompletedNo Results AvailableGastroparesisDrug: GSK1322888|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01294566
9711797117An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010CompletedHas ResultsDiabetes Mellitus, Type 2Drug: Administration of rosiglitazone/metforminhttps://ClinicalTrials.gov/show/NCT01294553
9711897118Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly CohortCompletedNo Results AvailableAlzheimer's DiseaseDrug: Drug: E2609|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01294540
9711997119Wireless Stimulation Endocardially for Cardiac Resynchronization TherapyActive, not recruitingNo Results AvailableHeart Failure|Ventricular Dysfunction|CardiomyopathyDevice: Wireless cardiac stimulator implant to pace the left ventricle for CRThttps://ClinicalTrials.gov/show/NCT01294527
9712097120Novel Non-Invasive Monitoring Parameter in Healthy VolunteersCompletedHas ResultsNo Conditions|Focus is Respiratory Ratehttps://ClinicalTrials.gov/show/NCT01294514
9712197121Decreasing Medication Errors by Caregivers Using a Health Literacy InterventionTerminatedNo Results AvailableMedication Administration|Medication ErrorsOther: Medication administration educational modulehttps://ClinicalTrials.gov/show/NCT01294501
9712297122Using Technology to Augment the Implementation and Effectiveness of PCITCompletedNo Results AvailableChild Externalizing ProblemsBehavioral: Parent-Child Interaction Therapyhttps://ClinicalTrials.gov/show/NCT01294488
9712397123Preventing Child Maltreatment Through A Cellular-Phone Technology-Based Parenting ProgramCompletedNo Results AvailableChild MaltreatmentBehavioral: Planned Activities Traininghttps://ClinicalTrials.gov/show/NCT01294475
9712497124Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)CompletedHas ResultsAcute Coronary Syndrome|Percutaneous Coronary InterventionDrug: Ticagrelor|Drug: Clopidogrel|Drug: Acetylsalicylic acid ASAhttps://ClinicalTrials.gov/show/NCT01294462
9712597125Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval RegistryCompletedHas ResultsHeart FailureDevice: MADIT-CRT ICD|Device: MADIT-CRT CRT-Dhttps://ClinicalTrials.gov/show/NCT01294449
9712697126Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes MellitusCompletedHas ResultsType2 Diabetes|High Blood SugarDrug: Dapagliflozinhttps://ClinicalTrials.gov/show/NCT01294436
9712797127Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes MellitusCompletedHas ResultsType 2 Diabetes|High Blood SugarDrug: Dapagliflozin|Drug: Dapagliflozin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01294423
9712897128Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative ColitisCompletedNo Results AvailableColitis, UlcerativeDrug: Placebo|Drug: Placebo|Drug: Anti-IP-10 Antibody|Drug: Anti-IP-10 Antibody|Drug: Anti-IP-10 Antibody|Drug: Anti-IP-10 Antibody|Drug: Anti-IP-10 Antibody|Drug: Anti-IP-10 Antibodyhttps://ClinicalTrials.gov/show/NCT01294410
9712997129Effects of Denosumab on the Pharmacokinetics of EtanerceptActive, not recruitingNo Results AvailablePostmenopausal|Osteopenia|Rheumatoid Arthritis|OsteoporosisDrug: Etanercept|Drug: Denosumabhttps://ClinicalTrials.gov/show/NCT01294397
9713097130Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye DiseaseCompletedHas ResultsDry Eye SyndromesDrug: carboxymethylcellulose sodium based New Eye Drop Formulation 1|Drug: carboxymethylcellulose sodium based New Eye Drop Formulation 2|Drug: carboxymethylcellulose sodium based Eye Dropshttps://ClinicalTrials.gov/show/NCT01294384
9713197131Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)CompletedHas ResultsGenital Endometriosishttps://ClinicalTrials.gov/show/NCT01294371
9713297132Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP TrialCompletedNo Results AvailableHistologically or Cytologically Confirmed Pancreatic Ca|Unresectable or Borderline Resectable Pancreatic CaDrug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT01294358
9713397133Personalized Genomic ResearchRecruitingNo Results AvailableGenetics|Genetic Disease|Genetic Linkage|Birth Defects|Genetic Variationhttps://ClinicalTrials.gov/show/NCT01294345
9713497134Effect of Aerobic Exercise Training on Cardiorespiratory Function in Patients With Traumatic Brain InjuryCompletedNo Results AvailableExercise|Fatigue|Physical Fitness|Traumatic Brain InjuryOther: Rehabilitationhttps://ClinicalTrials.gov/show/NCT01294332
9713597135Evaluation of Cortisol Resistance in Young Endurance-trained and Elderly MenSuspendedNo Results AvailableCortisol Resistance|Negative Feedback|ACTH|Mineralcorticoid|Glucocorticoidhttps://ClinicalTrials.gov/show/NCT01294319
9713697136MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride TherapyActive, not recruitingNo Results AvailableAdenosquamous Lung Carcinoma|Bronchioloalveolar Carcinoma|Large Cell Lung Carcinoma|Lung Adenocarcinoma|Recurrent Non-Small Cell Lung Carcinoma|Squamous Cell Lung CarcinomaDrug: Akt Inhibitor MK2206|Drug: Erlotinib Hydrochloride|Other: Laboratory Biomarker Analysis|Other: Pharmacological Studyhttps://ClinicalTrials.gov/show/NCT01294306
9713797137TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerCompletedNo Results AvailableMalignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent OvaDrug: TLR8 Agonist VTX-2337|Other: Diagnostic Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Pegylated Liposomal Doxorubicin Hydrochloride|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT01294293
9713897138Biomarkers in Predicting Response in Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant ChemotherapyRecruitingNo Results AvailableLung CancerOther: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT01294280
9713997139Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia AblationCompletedNo Results AvailableVentricular TachycardiaDevice: Impella 2.5 Circulatory Support system insertionhttps://ClinicalTrials.gov/show/NCT01294267
9714097140Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Moist Wound Healing Dressing Alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor SitesCompletedNo Results AvailableAccelerating the Epithelialization of Split Thickness Skin GraftDrug: Oleogel-S10|Procedure: Moist wound healing dressings alone (Mepilex) on the other half of the skin graft donor sitehttps://ClinicalTrials.gov/show/NCT01294254

* Görseller ve İçerik tekif hakkına sahip olabilir